Synthetic Biology — Golden Land Of Startups?

2 min read

Synthetic biology is the branch of biotech that is about creating new biological parts from scratch or from templates in nature. It is often about genes or proteins that can be used in research but increasingly in commercial spaces like agriculture, industry, medicine and even computing.  At Tau Ventures we are investors in digital health (besides enterprise and to a much smaller degree automation) but increasingly finding that synthetic biology is paving the way for biotech overall to be more software driven. It makes sense given that creating or repurposing new biological agents requires a high degree of modeling in…...

This article is free to read

Login to read the full article


OR
Amit Garg I have been in Silicon Valley for 20 years -- at Samsung NEXT Ventures, running my own startup (as of May 2019 a series D that has raised $120M and valued at $450M), at Norwest Ventures, and doing product and analytics at Google. My academic training is BS in computer science and MS in biomedical informatics, both from Stanford, and MBA from Harvard. I speak natively 3 languages, live carbon-neutral, am a 70.3 Ironman finisher, and have built a hospital in rural India serving 100,000 people.

Schedule a DDIChat with Amit Garg

app.ddichat.com/experts/amit-garg

Follow DDI

Gain Access to Expert Views

We won't send you spam. Unsubscribe at any time.